Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III

The adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against influenza for infants but is not publicly funded (NPF). The objective of this prospective cohort study of parents with children 6 through 23 months of age was to understand how NPF status influences parental perce...

詳細記述

書誌詳細

主要な著者:	William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-10-01
シリーズ:	Vaccines
主題:	approved vaccine unfunded vaccine parental acceptance vaccine hesitancy influenza
オンライン･アクセス:	https://www.mdpi.com/2076-393X/10/10/1769
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!